AADI - Aadi Bioscience, Inc.
IEX Last Trade
3.02
0 0%
Share volume: 441,740
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$3.02
-0.58
-0.16%
Summary score
9%
Profitability
0%
Dept financing
23%
Liquidity
72%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-12.51%
Return on sales
-342.48%
Return on invested capital
0%
Total debt ratio
16.27%
Debt ratio change over timeo
0%
Current Ratio
7.97%
Quick Ratio
7.79%
Cash Position Ratio
4.52%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-15.48%
Return on sales
-270.68%
Return on invested capital
0%
Total debt ratio
20.31%
Debt ratio change over timeo
0%
Current Ratio
4.74%
Quick Ratio
4.45%
Cash Position Ratio
2.22%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-17.57%
Return on sales
-364.51%
Return on invested capital
0%
Total debt ratio
18.56%
Debt ratio change over time
0%
Current Ratio
5.16%
Quick Ratio
4.86%
Cash Position Ratio
2.71%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AADI | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 13.03% | 18.15% | 6.63% |
| Return on assets | -12.51% | 2.28% | 3.22% | 5.84% |
| Return on sales | -342.48% | 27.95% | 31.46% | 43.41% |
| Return on invested capital | 0% | 2.07% | 5.53% | 34.89% |
| Profitability | 0% | 45% | 61% | 84% |
| Total debt ratio | 16.27% | 91.02% | 90.77% | 24.67% |
| Debt ratio change over time | 0% | 435.59% | 17.23% | -0.06% |
| Dept financing | 4% | 50% | 26% | 7% |
| Current Ratio | 4.74% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 4.45% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 2.22% | 0.31% | 0.49% | 2.77% |
| Liquididy | 75% | 7% | 15% | 44% |
| Short-term ratios | AADI | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 5.91% |
| Return on assets | -15.48% | 1.6% | 2.14% | 4.97% |
| Return on sales | -270.68% | 24.8% | 18.91% | 42.59% |
| Return on invested capital | 0% | 0% | 0% | 23.7% |
| Profitability | 0% | 23% | 22% | 100% |
| Total debt ratio | 20.31% | 94.49% | 93.35% | 24.56% |
| Debt ratio change over time | 0% | 0% | 0% | -0.62% |
| Dept financing | 30% | 25% | 25% | 6% |
| Current Ratio | 4.74% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 4.45% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 2.22% | 0.31% | 0.49% | 2.77% |
| Liquididy | 70% | 11% | 17% | 63% |